Ainos, Inc. (NASDAQ:AIMD) Short Interest Update

Ainos, Inc. (NASDAQ:AIMD) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 634,100 shares, an increase of 258.0% from the December 31st total of 177,100 shares. Approximately 14.5% of the company’s shares are short sold. Based on an average trading volume of 621,400 shares, the short-interest ratio is currently 1.0 days.

Ainos Trading Down 0.3 %

Shares of AIMD stock opened at $0.68 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.33 and a current ratio of 1.37. The company has a 50 day moving average price of $0.54 and a 200 day moving average price of $0.56. Ainos has a fifty-two week low of $0.40 and a fifty-two week high of $3.10.

Ainos (NASDAQ:AIMD) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.33) earnings per share for the quarter.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.